FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002040571> ?p ?o ?g. }

• W2002040571 endingPage "16993" @default.
• W2002040571 startingPage "16987" @default.
• W2002040571 abstract "Grb10 is a member of adapter proteins that are thought to play a role in receptor tyrosine kinase-mediated signal transduction. Grb10 expression levels can influence Akt activity, and Grb10 may act as an adapter involved in the relocalization of Akt to the cell membrane. Here we identified 14-3-3 as a binding partner of Grb10 by employing a yeast two-hybrid screen. The 14-3-3·Grb10 interaction requires phosphorylation of Grb10, and only the phosphorylated form of Grb10 co-immunoprecipitates with endogenous 14-3-3. We could identify a putative phosphorylation site in Grb10, which is located in a classical 14-3-3 binding motif, RSVSEN. Mutation of this site in Grb10 diminished binding to 14-3-3. Thus, Grb10 exists in two different states of phosphorylation and complexes with 14-3-3 when phosphorylated on serine 428. We provide evidence that Akt directly binds Grb10 and is able to phosphorylate Grb10 in an in vitro kinase assay. Based on these findings, we propose a regulatory circuitry involving a phosphorylation-regulated complex formation of Grb10 with 14-3-3 and Akt. Grb10 is a member of adapter proteins that are thought to play a role in receptor tyrosine kinase-mediated signal transduction. Grb10 expression levels can influence Akt activity, and Grb10 may act as an adapter involved in the relocalization of Akt to the cell membrane. Here we identified 14-3-3 as a binding partner of Grb10 by employing a yeast two-hybrid screen. The 14-3-3·Grb10 interaction requires phosphorylation of Grb10, and only the phosphorylated form of Grb10 co-immunoprecipitates with endogenous 14-3-3. We could identify a putative phosphorylation site in Grb10, which is located in a classical 14-3-3 binding motif, RSVSEN. Mutation of this site in Grb10 diminished binding to 14-3-3. Thus, Grb10 exists in two different states of phosphorylation and complexes with 14-3-3 when phosphorylated on serine 428. We provide evidence that Akt directly binds Grb10 and is able to phosphorylate Grb10 in an in vitro kinase assay. Based on these findings, we propose a regulatory circuitry involving a phosphorylation-regulated complex formation of Grb10 with 14-3-3 and Akt. Grb10 is a member of adapter proteins that include Grb7 and Grb14 (1Daly R.J. Cell Signal. 1998; 10: 613-618Crossref PubMed Scopus (102) Google Scholar). These adapter proteins share similar structural organizations, including an N-terminal proline-rich region, a central segment named the GM region (1Daly R.J. Cell Signal. 1998; 10: 613-618Crossref PubMed Scopus (102) Google Scholar) with a PH 1The abbreviations used are: PH, pleckstrin homology; FCS, fetal calf serum; GST, glutathione S-transferase; OA, okadaic acid; PDK, phosphoinositide-dependent kinase; PP, protein phosphatase; PI, phosphatidylinositol; Pipes, 1,4-piperazinediethanesulfonic acid; Ser(P), phosphoserine; WT, wild type. 1The abbreviations used are: PH, pleckstrin homology; FCS, fetal calf serum; GST, glutathione S-transferase; OA, okadaic acid; PDK, phosphoinositide-dependent kinase; PP, protein phosphatase; PI, phosphatidylinositol; Pipes, 1,4-piperazinediethanesulfonic acid; Ser(P), phosphoserine; WT, wild type. domain, and a C-terminal Src homology 2 (SH2) domain. Grb10 associates with a variety of growth factors at the cell surface, such as the insulin growth factor receptor (2Liu F. Roth R.A. Mol. Cell. Biochem. 1998; 182: 73-78Crossref PubMed Scopus (31) Google Scholar), and with intracellular protein kinases like Raf1 and MEK1 (3Nantel A. Huber M. Thomas D.Y. J. Biol. Chem. 1999; 274: 35719-35724Abstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar) via its SH2 domain. Serine/threonine phosphorylation of Grb10 in response to insulin (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar), as well as tyrosine phosphorylation in response to Tec (5Mano H. Ohya K. Miyazato A. Yamashita Y. Ogawa W. Inazawa J. Ikeda U. Shimada K. Hatake K. Kasuga M. Ozawa K. Kajigaya S. Genes Cells. 1998; 3: 431-441Crossref PubMed Scopus (36) Google Scholar) and Src (6Langlais P. Dong L.Q. Hu D. Liu F. Oncogene. 2000; 19: 2895-2903Crossref PubMed Scopus (36) Google Scholar), has been described. Interestingly, previously reported data have shown that the incubation with wortmannin, a PI 3-kinase inhibitor, abolishes Grb10 phosphorylation (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar), implicating a kinase downstream of the PI 3-kinase pathway as being responsible for Grb10 phosphorylation. The finding of four different splicing variants of Grb10 (human Grb10α, β, γ, and δ) may explain the controversy about the specific role of Grb10 as an activator or an inhibitor in particular signal transduction processes (7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar). Three isoforms (β, γ, and δ) of Grb10 contain an intact PH domain, and one isoform lacks a PH domain (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar). Our laboratory has demonstrated that overexpression of a Grb10 isoform with an intact PH domain leads to Akt activation (7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar), whereas overexpression of Grb10 lacking an intact PH domain abolishes this activation. These data indicated the necessity of the Grb10 PH domain for its stimulatory effect on Akt. In accordance with this hypothesis, overexpression of a Grb10 isoform with an intact PH domain has a positive, stimulatory, and mitogenic effect on platelet-derived growth factor-BB, insulin growth factor-1, and insulin action (8Wang J. Dai H. Yousaf N. Moussaif M. Deng Y. Boufelliga A. Swamy O.R. Leone M.E. Riedel H. Mol. Cell. Biol. 1999; 19: 6217-6228Crossref PubMed Scopus (100) Google Scholar). Expression of a Grb10 isoform lacking the PH domain inhibits insulin-stimulated substrate tyrosine phosphorylation and the activation of PI 3-kinase (9Liu F. Roth R.A. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 10287-10291Crossref PubMed Scopus (150) Google Scholar). Therefore, the natural occurrence of different Grb10 isoforms with and without an intact PH domain may provide a mechanism for different regulation of signal transduction processes. However, recent additional studies showed controversial results regarding the role of Grb10 with an intact PH domain in insulin signaling (10Deng Y. Bhattacharya S. Swamy O.R. Tandon R. Wang Y. Janda R. Riedel H. J. Biol. Chem. 2003; 278: 39311-39322Abstract Full Text Full Text PDF PubMed Scopus (42) Google Scholar, 11Langlais P. Dong L.Q. Ramos F.J. Hu D. Li Y. Quon M.J. Liu F. Mol. Endocrinol. 2003; 18: 350-358Crossref PubMed Scopus (50) Google Scholar, 12Wick K.R. Werner E.D. Langlais P. Ramos F.J. Dong L.Q. Shoelson S.E. Liu F. J. Biol. Chem. 2003; 278: 8460-8467Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar). The use of different cellular systems may account for these differences. Interestingly, the fusion of Grb10 to Akt revealed a constitutive active Akt chimera, further suggesting an important role of Grb10 in Akt regulation (7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar). In addition, a Grb10 mutant, which is constitutively attached to the plasma membrane, induced strong Akt activation and had a potent anti-apoptotic effect in Ba/F3 cells grown without survival factors. 2S. Urschel and J. Duyster, submitted for publication. 2S. Urschel and J. Duyster, submitted for publication. Together, these data suggest a mechanism of Akt activation through Grb10. Because Akt activation is a multistep process that requires the membrane translocation of the protein, Grb10 may act as a vehicle for Akt that facilitates the membrane localization of Akt. One of the first identified substrates of Akt was the Bcl2 family member Bad (13Datta S.R. Dudek H. Tao X. Masters S. Fu H. Gotoh Y. Greenberg M.E. Cell. 1997; 91: 231-241Abstract Full Text Full Text PDF PubMed Scopus (4920) Google Scholar). Akt phosphorylation of Bad mediates its interaction with 14-3-3, which prevents Bad from binding to Bcl-XL and suppresses apoptosis (14Downward J. Nat. Cell Biol. 1999; 1: E33-E35Crossref PubMed Scopus (203) Google Scholar). Another substrate of Akt is FKHRL1, a member of the Forkhead family of transcription factors (15Brunet A. Bonni A. Zigmond M.J. Lin M.Z. Juo P. Hu L.S. Anderson M.J. Arden K.C. Blenis J. Greenberg M.E. Cell. 1999; 96: 857-868Abstract Full Text Full Text PDF PubMed Scopus (5381) Google Scholar). Akt phosphorylates FKHRL1 in the presence of survival factors, leading to FKHRL1 binding to 14-3-3. Binding to 14-3-3 causes cytosolic sequestration of FKHRL1 and prevents the nuclear translocation of FKHRL1. Survival factor withdrawal mediates the dephosphorylation and nuclear translocation of FKHRL1, where the expression of pro-apoptotic molecules such as the Fas ligand is initiated by FKHRL1. In both cases, the pro-apoptotic function of these proteins is suppressed by interaction with 14-3-3, mediating sequestration in an appointed cell compartment. The interest in 14-3-3 in recent years has increased intensively because of the important interaction partners of 14-3-3 that are involved in cell cycle regulation (Cdc25), transcriptional control of gene expression (FKHRL members), or apoptosis (Bad). 14-3-3 proteins are highly conserved and ubiquitously expressed, and there exist to date seven isoforms in human cells and up to 15 in plants. These proteins generate homodimers and heterodimers (16Xiao B. Smerdon S.J. Jones D.H. Dodson G.G. Soneji Y. Aitken A. Gamblin S.J. Nature. 1995; 376: 188-191Crossref PubMed Scopus (400) Google Scholar, 17Liu D. Bienkowska J. Petosa C. Collier R.J. Fu H. Liddington R. Nature. 1995; 376: 191-194Crossref PubMed Scopus (438) Google Scholar) and bind discrete phosphoserine/threonine motifs (18Yaffe M.B. Rittinger K. Volinia S. Caron P.R. Aitken A. Leffers H. Gamblin S.J. Smerdon S.J. Cantley L.C. Cell. 1997; 91: 961-971Abstract Full Text Full Text PDF PubMed Scopus (1339) Google Scholar, 19Muslin A.J. Tanner J.W. Allen P.M. Shaw A.S. Cell. 1996; 84: 889-897Abstract Full Text Full Text PDF PubMed Scopus (1185) Google Scholar). Three preferred binding motifs of 14-3-3 have been described, namely Arg-Ser-X-Ser(P)-X-Pro, Arg-X-Arg-X-X-Ser(P)-X-Pro, and Arg-X-X-Ser(P), where Ser(P) represents a phosphorylated serine. Most of the interaction partners of 14-3-3 contain one of these motifs. But association with proteins that do not contain either one of these motifs, e.g. protein kinase Cμ, and association with unphosphorylated proteins, such as exoenzyme S, has been described (20Hausser A. Storz P. Link G. Stoll H. Liu Y.C. Altman A. Pfizenmaier K. Johannes F.J. J. Biol. Chem. 1999; 274: 9258-9264Abstract Full Text Full Text PDF PubMed Scopus (91) Google Scholar, 21Masters S.C. Pederson K.J. Zhang L. Barbieri J.T. Fu H. Biochemistry. 1999; 38: 5216-5221Crossref PubMed Scopus (125) Google Scholar). In the present study we identified 14-3-3 as an interaction partner of Grb10. Phosphorylation of Grb10 is required for its interaction with 14-3-3 and is mediated by a 14-3-3 consensus binding site in Grb10. Based on these findings we present a hypothetical model of regulatory circuitry in which the phosphorylation of Grb10 regulates its interaction with 14-3-3 and Akt. Cell Lines, Expression Constructs, and Transfections—293, COS1, COS7, HeLa, and U2OS cells were maintained in Dulbecco's modified Eagle's medium with 10% FCS. Ba/F3 cells were incubated in RPMI medium containing 10% FCS and murine interleukin-3. The murine Grb10 cDNA (pRK5 Grb10) was kindly provided by Renato Baserga of the Kimmel Cancer Institute, Philadelphia, PA. The human Grb10 cDNA (pBEX Grb10 gamma) was a kind gift from Feng Liu of the Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX. To obtain a FLAG-tagged murine Grb10, the cDNA was cloned into pCMVTag from Stratagene. For mutation of the Grb10 Ser-76 and Ser-428, the serine was changed to alanine by site-directed mutagenesis using appropriate primers. The 14-3-3 cDNA was isolated from the yeast DNA and cloned into pCMV-Myc tagged from Stratagene. To obtain higher expression levels, we cloned the Myc-tagged 14-3-3 cDNA into a pcDNA 3.1 vector (Invitrogen). The hemagglutinin-tagged protein kinase B-Akt construct (pCMV6 HA-Akt) was a kindly gift from Thomas Franke, Department of Pharmacology, Columbia University, New York, NY. 293 cells were transiently transfected with M-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethyl-ammonium methyl-sulfate (DOTAP liposomal transfection reagent; Roche Applied Science). COS1 and COS7 cells were transiently transfected with Gene Porter (GTS Inc., Biozol GmbH, Eching, Germany). Ba/F3 cells were stably transfected by electroporation and selection with 1 mg/ml G418 as described previously (22Bai R.Y. Jahn T. Schrem S. Munzert G. Weidner K.M. Wang J.Y. Duyster J. Oncogene. 1998; 17: 941-948Crossref PubMed Scopus (44) Google Scholar) (Calbiochem). In Vivo Labeling of Cells with 32Pi—HeLa cells either starved in 0.5% FCS, stimulated with 10% FCS, or treated with 0.5 μm okadaic acid (OA) were cultured in phosphate-free Dulbecco's modified Eagle's medium containing 0.2 mCi/ml 32Pi (Amersham Biosciences) for 2 h at 37 °C. Immunoprecipitations were performed from the corresponding lysates using either anti-Grb10 (Upstate Biotechnology, Lake Placid, NY) or control antiserum. In Vitro Translation—In vitro translation was performed with the TnT-coupled reticulocyte lysate system (Promega, Madison, WI) and [35S]methionine. In Vitro Kinase Assay—Glutathione S-transferase (GST)-Grb10 and Bad (Upstate Biotechnology) were incubated with active Akt, inactive Akt, or buffer alone, and the kinase assay was performed with 32P according to the manufacturer's instructions (Upstate Biotechnology). The reactions were resolved by SDS-Page and visualized by autoradiography (BioMax, Kodak). Yeast Two-hybrid System—The DNA of Grb10 was cloned with BamHI/SalI into the yeast expression vector BTM116 BamHI/XhoI. A cDNA library derived from K562 cells was used (Clontech) as prey. Interactions were tested in the L40 yeast strain by assaying activation of the HIS3 reporter as described preciously (22Bai R.Y. Jahn T. Schrem S. Munzert G. Weidner K.M. Wang J.Y. Duyster J. Oncogene. 1998; 17: 941-948Crossref PubMed Scopus (44) Google Scholar). Antibody Preparation—To generate the antiphospho-Grb10 antibody, a phosphopeptide corresponding to amino acids 423–436 of the human Grb10 cDNA sequence was used to raise polyclonal antibodies in rabbits (Davids Biotechnology, Regensburg, Germany). The resulting serum was affinity purified using both the cognate phosphopeptide and the non-phosphopeptide. Immunoprecipitations and Western Blotting—Immunoprecipitation and immunoblotting were performed in accordance with standard procedures as described previously (23Duyster J. Baskaran R. Wang J.Y. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 1555-1559Crossref PubMed Scopus (106) Google Scholar) with the following antibodies: agarose-coupled anti-FLAG M2 (Sigma), mouse anti-FLAG M2 (Stratagene), anti-Myc 9E11 (Sigma), anti-14-3-3β K19 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-14-3-3β H8 (Santa Cruz Biotechnology), anti-Grb10 (Upstate Biotechnology), and goat anti-Akt C-20 (Santa Cruz Biotechnology). The phospho-specific Akt antibody (Ser-473) was obtained from New England Biolabs. For co-immunoprecipitation in tissues, the proteins were extracted from mouse lung by homogenization. The experiment was as described by O'Kelly et al. (24O'Kelly I. Butler M.H. Zilberberg N. Goldstein S.A. Cell. 2002; 111: 577-588Abstract Full Text Full Text PDF PubMed Scopus (248) Google Scholar, 25Deleted in proofGoogle Scholar, 26Deleted in proofGoogle Scholar, 27Chiang C.W. Harris G. Ellig C. Masters S.C. Subramanian R. Shenolikar S. Wadzinski B.E. Yang E. Blood. 2001; 97: 1289-1297Crossref PubMed Scopus (131) Google Scholar, 28Deleted in proofGoogle Scholar). The immunoprecipitation was performed with 5 μg of a polyclonal anti-Grb10 antibody or a control antibody. The immunocomplexes were isolated with 40 μl of protein A beads. The proteins were separated with SDS-PAGE (12% for 14-3-3 and 8% for Grb10 separation). Blots were developed using SuperSignal chemoluminescent substrates from Pierce. GST Fusion Construct and GST Binding Studies—The 14-3-3 cDNA was cloned into the pGEX vector to obtain a GST-14-3-3 construct. The procedure for pull-down assays has been described previously (22Bai R.Y. Jahn T. Schrem S. Munzert G. Weidner K.M. Wang J.Y. Duyster J. Oncogene. 1998; 17: 941-948Crossref PubMed Scopus (44) Google Scholar). Cell lysates were incubated with the GST fusion construct or with GST alone. Bound fractions of recombinant proteins were separated by SDS-PAGE. A purified GST fusion protein of full-length Akt was obtained from a commercial source (Upstate Biotechnology). Treatment with Phosphatase, Wortmannin, or Okadaic Acid—Cells were transfected and harvested, and immunoprecipitation experiments were performed. The bound fractions were washed with phosphatase buffer (Pipes, pH 6) and incubated for the indicated time points at 30 °C with 0.4 units phosphatase (Sigma) with or without phosphatase inhibitors (NaF, ortho-vanadate, and glycerol phosphate). Cells were incubated with OA (Roche, Mannheim, Germany) for the indicated time points at the described concentrations (Fig. 1, C and D). Cells were incubated for 30 min in Dulbecco's modified Eagle's medium lacking FCS containing 500 nm wortmannin (Sigma). Untreated cells were incubated in media containing the same concentration of Me2SO. The Serine/Threonine Kinase Akt Interacts Directly with the Adapter Protein Grb10 and Phosphorylates Grb10 in Vitro— First we wanted to determine whether the described coimmunoprecipitation between Grb10 and Akt is a direct interaction between the two proteins (7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar). We performed GST pull-downs with in vitro translated, 35S-labeled Grb10 and purified GSTAkt protein (Fig. 1A). Both, Grb10WT and Grb10ΔPH showed a specific and direct interaction with Akt (Fig. 1A). We noted previously a mobility shift of Grb10 in SDS gels in Mo7e and K562 cells expressing the c-kit receptor or Bcr-Abl (7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar), respectively. Other groups reported tyrosine phosphorylation of Grb10 as an effect of Tec (5Mano H. Ohya K. Miyazato A. Yamashita Y. Ogawa W. Inazawa J. Ikeda U. Shimada K. Hatake K. Kasuga M. Ozawa K. Kajigaya S. Genes Cells. 1998; 3: 431-441Crossref PubMed Scopus (36) Google Scholar), as well as serine phosphorylation in response to insulin stimulation (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar). Additional data revealed that incubation with wortmannin, an inhibitor of the PI 3-kinase/Akt pathway, abolished phosphorylation of Grb10, implicating a kinase downstream of this pathway (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar, 7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar). Because of their direct association, we assumed that Akt itself may be the kinase phosphorylating Grb10. In vitro kinase assays were performed with GST-Grb10 and with kinase active and inactive Akt. Bad, a known substrate of Akt, was used as a positive control (13Datta S.R. Dudek H. Tao X. Masters S. Fu H. Gotoh Y. Greenberg M.E. Cell. 1997; 91: 231-241Abstract Full Text Full Text PDF PubMed Scopus (4920) Google Scholar) (Fig. 1B, top section). The autoradiogram showed that GST-Grb10 incorporated 32P in the presence of kinase-active Akt. In this assay, the phosphorylation intensity was comparable with the phosphorylation of Bad (Fig. 1B). In the presence of kinase-inactive Akt, no 32P signal could be detected. Coomassie staining of the gel demonstrated equal levels of GST-Grb10 (Fig. 1B, bottom section). Thus, we identified Akt as a kinase able to phosphorylate Grb10 in an in vitro kinase assay. Phosphorylation is often regulated by a balance of kinases and phosphatases. Okadaic acid is a potent inhibitor of the protein phosphatases PP1 and PP2A. Okadaic acid causes a 2.5–3-fold higher phosphorylation of many proteins (27Chiang C.W. Harris G. Ellig C. Masters S.C. Subramanian R. Shenolikar S. Wadzinski B.E. Yang E. Blood. 2001; 97: 1289-1297Crossref PubMed Scopus (131) Google Scholar), because the balance shifts in favor of phosphorylation. To investigate whether Grb10 phosphorylation is affected by phosphatase inhibitors, we treated COS1 cells expressing Grb10 with OA and harvested the cells after different time points (Fig. 1C). Western blot analysis showed that after 40 min of incubation with OA, Grb10 started to undergo a mobility shift (Fig. 1C, lane labeled +40min). It is known that OA inhibits PP1 in the micromolar range and PP2A in the nanomolar range (27Chiang C.W. Harris G. Ellig C. Masters S.C. Subramanian R. Shenolikar S. Wadzinski B.E. Yang E. Blood. 2001; 97: 1289-1297Crossref PubMed Scopus (131) Google Scholar). We transfected COS1 cells with FLAG-tagged Grb10WT or with Bad as a control, because PP2A is known to dephosphorylate Bad (27Chiang C.W. Harris G. Ellig C. Masters S.C. Subramanian R. Shenolikar S. Wadzinski B.E. Yang E. Blood. 2001; 97: 1289-1297Crossref PubMed Scopus (131) Google Scholar). The cells were treated with the indicated concentrations of OA (Fig. 1D). Western blot analysis revealed that the mobility shift of Grb10 already occurs in the presence of nanomolar concentrations of OA indicating that PP2A and not PP1 is the phosphatase obligated for Grb10 dephosphorylation (Fig. 1D, top). To demonstrate that phosphorylation of endogenous Grb10 occurs in vivo, we incubated HeLa cells, either starved or incubated with agents that induce Grb10 phosphorylation, with 32P and performed immunoprecipitations of the corresponding lysates using anti-Grb10 or control antiserum. As depicted in Fig. 1E, phosphorylation of Grb10 was detectable in FCS-stimulated cells and at a reinforced level in cells treated with OA, whereas no phosphorylation was observed in serum-starved cells. The control precipitates did not give rise to unspecific signals. To further substantiate Grb10 phosphorylation, we generated a polyclonal phospho-specific Grb10 antibody raised against a phosphopeptide of Grb10. To test for specificity, we immunoprecipitated Grb10 from lysates derived from HeLa cells that were either serum-starved or stimulated with FCS and processed the respective blot for Western blot analysis. The phospho-Grb10 antiserum detected Grb10 only in the precipitate from FCS-stimulated cells, whereas no signal was observed in the serum-starved sample (Fig. 1F, top). Equal amounts of precipitated Grb10 were detectable in the Grb10 immunostain (Fig. 1F, bottom). We next performed Western blot analysis of lysates derived from HeLa cells that were serum-starved, stimulated with FCS, or treated with OA. As shown in Fig. 1G, top, the phospho-specific antiserum detected Grb10 only when stimulated with FCS and to a even higher extent when treated with OA. Only background signals were detectable in serum-starved cells. The specific phospho-Grb10 signal was abolished upon the addition of the relevant phosphopeptide (Fig. 1G, middle). Of note, an up-shift of Grb10 upon FCS stimulation or treatment with OA was not observed with the endogenous protein as compared with the overexpressed FLAG-tagged Grb10 protein. A Yeast Two-hybrid Screen Identified 14-3-3 as a New Binding Partner of Grb10 —From our data we hypothesized that Grb10 exists in two different states of phosphorylation that may regulate its interaction with other signaling molecules. To identify such binding proteins, we performed a yeast two-hybrid screen of a K562 cDNA library with a Grb10·LexA fusion protein as bait. In two independent screens the strongest interaction partner of Grb10 was identified to be the ϵ isoform of 14-3-3. To confirm the interaction between Grb10 and 14-3-3 in vitro, we performed GST pull-down assays. We expressed Grb10WT in COS1 cells and were able to precipitate Grb10 with GST-14-3-3 (Fig. 2A). Next, we transiently expressed FLAG-tagged Grb10 and Myc-tagged 14-3-3 in COS1 cells (Fig. 2B) and 293 cells (Fig. 2C) and performed co-immunoprecipitations in both directions. Western blotting revealed a specific interaction between Grb10 and 14-3-3 in both cell lines. Grb10·14-3-3 Interaction Requires Phosphorylation of Grb10— 14-3-3 proteins specifically recognize phosphorylated serine and threonine residues (29Michaud N.R. Fabian J.R. Mathes K.D. Morrison D.K. Mol. Cell. Biol. 1995; 15: 3390-3397Crossref PubMed Scopus (189) Google Scholar) but interact with unphosphorylated proteins as well (21Masters S.C. Pederson K.J. Zhang L. Barbieri J.T. Fu H. Biochemistry. 1999; 38: 5216-5221Crossref PubMed Scopus (125) Google Scholar). To investigate whether this interaction is phosphorylation-dependent, we treated Grb10·14-3-3 co-immunoprecipitates with phosphatase. Transiently expressed FLAG-tagged Grb10 and Myc-tagged 14-3-3 in 293 cells were precipitated with an anti-Myc antibody. The precipitated proteins were treated with and without an unspecific phosphatase or with phosphatase together with a specific phosphatase inhibitor (Fig. 3A). The untreated co-immunoprecipitation showed a strong association between Grb10 and 14-3-3 (Fig. 3A, top section, lane labeled Ø). Incubation with the unspecific phosphatase resulted in a greatly diminished interaction between Grb10 and 14-3-3 (Fig. 3A, top section, lanes labeled +/5min and +/10min). The presence of phosphatase inhibitors could partially restore the interaction (Fig. 3A, top section, lane labeled +/5min/+Inhibitor). The second section from the top in Fig. 3A shows equal amounts of precipitated 14-3-3. The center section of Fig. 3A shows the control immunoprecipitation (IP), and the two bottom sections show similar expression levels of Grb10 and 14-3-3 in the cell lysates. These data indicate a requirement of Grb10 phosphorylation for 14-3-3 interaction. To emphasize the necessity of Grb10 phosphorylation for 14-3-3 interaction, we treated cells with OA and performed co-immunoprecipitations. Co-immunoprecipitation experiments revealed a greatly enhanced association between 14-3-3 and the hyperphosphorylated form of Grb10 in the presence of OA compared with the interaction between 14-3-3 and Grb10 in untreated cells (Fig. 3B, top section). Next, we were interested as to whether endogenous 14-3-3 associates with Grb10. Therefore, we stably expressed FLAG-tagged Grb10 or empty vector as a control in Ba/F3 cells. We treated the cells with or without OA and performed co-immunoprecipitation experiments (Fig. 3C). Only the hyperphosphorylated form of Grb10 was able to form a complex with endogenous 14-3-3, whereas we could not detect an interaction between Grb10 and endogenous 14-3-3 in untreated cells. The binding specificity was confirmed by the vector control reaction (Fig. 3C, two lanes labeled PCMVØ). To ascertain the interaction between the endogenous proteins, we stimulated serum starved HeLa cells with serum in the presence of OA and performed co-immunoprecipitations (Fig. 3D). The experiment showed an interaction between endogenous 14-3-3 and endogenous Grb10 only in serum-stimulated cells (Fig. 3D, left sections, two right lanes). Accordingly, 14-3-3 and Grb10 could be coprecipitated from murine lung tissue when a polyclonal antibody was used to immunoprecipitate Grb10 from mouse lung (Fig. 3E, top section). Interaction of Grb10 and 14-3-3 Is Wortmannin-sensitive— The phosphorylation of Grb10 is PI-3 kinase-dependent (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar, 7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar). Therefore, we tested whether the inhibition of Grb10 phosphorylation through the PI-3kinase inhibitor wortmannin is able to abolish the association between Grb10 and 14-3-3. We transiently co-expressed Grb10 and 14-3-3 and treated the cells with wortmannin. The cells were harvested, and co-immunoprecipitation experiments were performed. Wortmannin treatment reduced the association between Grb10 and 14-3-3 as compared with the Me2SO (DMSO) control (Fig. 4, top section). Identification of Serine 428 in Grb10 as the 14-3-3 Recognition Site—14-3-3 proteins recognize conserved motifs containing phosphoserine such as Arg-X-Arg-X-X-Ser(P)-X-Pro, Arg-Ser-X-Ser(P)-X-Pro, and Arg-X-X-Ser(P). We found two potential 14-3-3 binding sites in Grb10, namely serine 76 within a RXXSXP motif and serine 428 within a RSVSEN motif (Fig. 5A). Both residues were substituted with alanine by site-directed mutagenesis, and the ability of both mutants to bind 14-3-3 was examined. We transfected Grb10 WT, Grb10 S76A, and Grb10 S428A in COS1 cells and performed GST binding studies with GST-14-3-3 (Fig. 5B). Our data indicate that mutation at serine 428 impairs the ability of 14-3-3 to bind Grb10 (Fig. 5B, top section, lane labeled Grb10 S428A). The mutation of serine 76 to alanine did not affect 14-3-3 binding to Grb10 (Fig. 5B, top section, lane labeled Grb10 S76A). As a control, we incubated the Grb10 cell lysates with GST (Fig. 5B, middle section). The cell lysates used in this experiment are shown in Fig. 5B, bottom section. Grb10 Exists in Two Different States of Phosphorylation, i.e. in the Unphosphorylated Form It May Primarily Associate with Akt, and in the Phosphorylated Form It Interacts with 14-3-3— From our data we propose a hypothetical model in which Grb10 exists in two different states of phosphorylation (Fig. 6B). In the unphosphorylated state, Grb10 interacts with Akt. The Grb10·Akt complex translocates to the plasma membrane, where PDK1/2 phosphorylates Akt. The activated Akt phosphorylates Grb10, the Grb10·Akt complex dissociates, and the interaction with 14-3-3 occurs. The phosphorylation of Grb10 is the requirement for binding to 14-3-3. PP2A dephosphorylates Grb10, mediating dissociation of the Grb10·14-3-3 complex and leading to interaction with Akt. To further elucidate this hypothesis, we transfected COS1 cells with Akt, with or without 14-3-3, and with Grb10 WT and Grb10 S428A, the 14-3-3 binding mutant. Western blot analysis with the indicated antibodies revealed that Grb10 WT mediates Akt activation, as we reported previously (7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar) (Fig. 6A, top section, second lane from the left). However, co-expression of Grb10 and 14-3-3 resulted in a reduced Akt activation (Fig. 6A, top section, second lane from the right). Interestingly, the expression of the Grb10 S428A mutant, which is unable to interact with 14-3-3, seems to result in an enhanced activation of Akt (Fig. 6A, top section, far right lane). This could be explained by the fact that the Grb10 molecule interacts either with Akt or with 14-3-3 in a competing fashion. By performing a yeast two-hybrid screen we identified the ϵ form of 14-3-3 as a new interaction partner of Grb10. We show that Grb10 binds 14-3-3 in vitro and in vivo. It has been shown that Grb10 is phosphorylated on serine/threonine residues (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar) and that incubation with the specific PI 3-kinase inhibitor wortmannin abolished Grb10 phosphorylation (4Dong L.Q. Du H. Porter S.G. Kolakowski Jr., L.F. Lee A.V. Mandarino L.J. Fan J. Yee D. Liu F. Mandarino J. J. Biol. Chem. 1997; 272: 29104-29112Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar). These data suggested that a kinase downstream of the PI 3-kinase pathway is responsible for Grb10 phosphorylation. We observed that the Grb10·14-3-3 interaction was diminished after wortmannin treatment, providing evidence that the interaction between Grb10 and 14-3-3 requires the phosphorylation of Grb10. Treatment with wortmannin inhibits the downstream target of PI 3-kinase Akt. In this study, we were able to show a direct interaction between Grb10 and Akt using purified proteins in an in vitro binding assay. Moreover, we demonstrate that Akt is capable of phosphorylating Grb10 in an in vitro kinase assay. Thus, Akt may be the kinase responsible for Grb10 phosphorylation and regulation of the Grb10·14-3-3 complex. The regulation of 14-3-3 interactions with signaling molecules by phosphorylation has been shown previously by other groups. For example, the interaction of 14-3-3 and PDK1 requires phosphorylation of PDK1 (30Sato S. Fujita N. Tsuruo T. J. Biol. Chem. 2002; 277: 39360-39367Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar). Muslin et al. identified a motif for 14-3-3 interactions (Arg-Ser-X-Ser(P)-X-Pro) (19Muslin A.J. Tanner J.W. Allen P.M. Shaw A.S. Cell. 1996; 84: 889-897Abstract Full Text Full Text PDF PubMed Scopus (1185) Google Scholar). Recent studies with phosphopeptide libraries revealed that there exist additional preferred motifs for 14-3-3 binding, Arg-X-Arg-X-X-Ser(P)-X-Pro or Arg-X-X-Ser(P) (18Yaffe M.B. Rittinger K. Volinia S. Caron P.R. Aitken A. Leffers H. Gamblin S.J. Smerdon S.J. Cantley L.C. Cell. 1997; 91: 961-971Abstract Full Text Full Text PDF PubMed Scopus (1339) Google Scholar). Grb10 contains two potential 14-3-3 binding motifs in its amino acid sequence 73RXXSXP78 and 427RSVSEN432. Site-directed mutagenesis of the target serines revealed that serine 428 within the RSVSEN motif is required for the Grb10·14-3-3 binding. Therefore, we propose that serine 428 within the RSVSEN motif of Grb10 may be one of the phosphorylation sites. Treatment of cells with the phosphatase inhibitor OA leads to the accumulation of phosphorylated Grb10. Because this accumulation is observed at a nanomolar concentration at which OA is a specific inhibitor of PP2A, this is a likely phosphatase to dephosphorylate Grb10. Binding of 14-3-3 to Grb10 was enhanced in cells treated with OA. In addition, the complex formation between endogenous 14-3-3 and Grb10 was only detectable after stimulation with serum and OA in various cell lines. There exist two explanations for the absent interaction between endogenous Grb10 and 14-3-3 in unstimulated or serum-starved cells. First, the level of Grb10 phosphorylation is too faint and, therefore, the affinity of 14-3-3 to Grb10 is too low. The second explanation involves the subcellular localization of the target protein. Without stimulation the two proteins may exist in two different cell compartments and, therefore, the two proteins could not associate. The fact that GST·14-3-3 pulls down overexpressed Grb10 WT but not the Grb10 S428A mutant from cell lysates argues for the first explanation. We have previously identified the serine/threonine kinase Akt as a binding partner of the adapter protein Grb10 (7Jahn T. Seipel P. Urschel S. Peschel C. Duyster J. Mol. Cell. Biol. 2002; 22: 979-991Crossref PubMed Scopus (85) Google Scholar). This interaction mediates the activation of Akt. These data differ from two recent studies by Wick et al. (12Wick K.R. Werner E.D. Langlais P. Ramos F.J. Dong L.Q. Shoelson S.E. Liu F. J. Biol. Chem. 2003; 278: 8460-8467Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar) and Langlais et al. (11Langlais P. Dong L.Q. Ramos F.J. Hu D. Li Y. Quon M.J. Liu F. Mol. Endocrinol. 2003; 18: 350-358Crossref PubMed Scopus (50) Google Scholar), who demonstrated that human Grb10γ with an intact PH domain has an inhibitory effect on Akt activation (11Langlais P. Dong L.Q. Ramos F.J. Hu D. Li Y. Quon M.J. Liu F. Mol. Endocrinol. 2003; 18: 350-358Crossref PubMed Scopus (50) Google Scholar, 12Wick K.R. Werner E.D. Langlais P. Ramos F.J. Dong L.Q. Shoelson S.E. Liu F. J. Biol. Chem. 2003; 278: 8460-8467Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar). Both studies observed their findings in CHO and HeLa cells, both stably expressing the insulin receptor. To rule out the possibility that the differences in these studies are due to the cell line or the Grb10 construct used, we transiently transfected Akt together with human Grb10γ or murine Grb10. In our hands overexpression of both forms of Grb10 induces an increase in Akt activation compared with that of the vector control in CHO cells (data not shown), although to a lower extent as compared with COS1 or 293 cells. Therefore, we conclude that Grb10 activates Akt in COS1 cells and to a lesser extent in parental CHO cells without expressing the insulin receptor. Many studies suggest a connection between Akt and 14-3-3. The serine/threonine kinase Akt phosphorylates Bad (13Datta S.R. Dudek H. Tao X. Masters S. Fu H. Gotoh Y. Greenberg M.E. Cell. 1997; 91: 231-241Abstract Full Text Full Text PDF PubMed Scopus (4920) Google Scholar) and FKHRL1 (15Brunet A. Bonni A. Zigmond M.J. Lin M.Z. Juo P. Hu L.S. Anderson M.J. Arden K.C. Blenis J. Greenberg M.E. Cell. 1999; 96: 857-868Abstract Full Text Full Text PDF PubMed Scopus (5381) Google Scholar), which is the requirement for the interaction of Bad and FKHRL1 with 14-3-3. New insights show that 14-3-3 even interacts directly with Akt (31Powell D.W. Rane M.J. Chen Q. Singh S. McLeish K.R. J. Biol. Chem. 2002; 277: 21639-21642Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar) and PDK1 (30Sato S. Fujita N. Tsuruo T. J. Biol. Chem. 2002; 277: 39360-39367Abstract Full Text Full Text PDF PubMed Scopus (81) Google Scholar). The association between 14-3-3 and PDK1 has an inhibitory effect on PDK1 activity, and the authors suggest that 14-3-3 has no effect on the translocation of PDK1. Additionally, the authors propose an inhibitory effect on Akt activity. These data show that 14-3-3 binding can have a direct effect on target protein activity. In addition, previous data characterize 14-3-3 proteins as gatekeepers (32Yaffe M.B. FEBS Lett. 2002; 513: 53-57Crossref PubMed Scopus (551) Google Scholar) and show that 14-3-3 can mediate the relocalization of nuclear ligands (33Brunet A. Kanai F. Stehn J. Xu J. Sarbassova D. Frangioni J.V. Dalal S.N. DeCaprio J.A. Greenberg M.E. Yaffe M.B. J. Cell Biol. 2002; 156: 817-828Crossref PubMed Scopus (441) Google Scholar). In this study we discovered a potential connection between the three proteins Akt, 14-3-3, and Grb10. In a hypothetical model we propose that Grb10 exists in two different states of phosphorylation. In the unphosphorylated state Grb10 interacts with Akt and recruits Akt to the membrane. Akt phosphorylates Grb10, mediating the interaction with 14-3-3. The interaction of phosphorylated Grb10 with 14-3-3 may lead to the translocation of Grb10 back to the cytosol. Here, PP2A could dephosphorylate Grb10 to allow a new interaction with Akt. We observed that the Grb10A428S mutant, which failed to interact with 14-3-3, enhances the activation of Akt as compared with Grb10WT. Therefore, it may also be true that Akt and 14-3-3 compete for the interaction with Grb10. In this scenario, 14-3-3 associates with Grb10 to prohibit the association of Grb10 with Akt. In summary, our data show that Grb10 interacts specifically with 14-3-3 in a phosphorylation-regulated manner. This interaction may represent an important part of a regulatory circuitry as depicted in Fig. 6B." @default.
• W2002040571 created "2016-06-24" @default.
• W2002040571 creator A5005996443 @default.
• W2002040571 creator A5006057529 @default.
• W2002040571 creator A5018962313 @default.
• W2002040571 creator A5059538708 @default.
• W2002040571 creator A5066200247 @default.
• W2002040571 creator A5088789978 @default.
• W2002040571 date "2005-04-01" @default.
• W2002040571 modified "2023-09-27" @default.
• W2002040571 title "Phosphorylation of Grb10 Regulates Its Interaction with 14-3-3" @default.
• W2002040571 cites W1518401857 @default.
• W2002040571 cites W1606738305 @default.
• W2002040571 cites W1769997374 @default.
• W2002040571 cites W1969744026 @default.
• W2002040571 cites W1971566284 @default.
• W2002040571 cites W1973556619 @default.
• W2002040571 cites W1990283596 @default.
• W2002040571 cites W2005500718 @default.
• W2002040571 cites W2011915114 @default.
• W2002040571 cites W2013452582 @default.
• W2002040571 cites W2015950029 @default.
• W2002040571 cites W2024153969 @default.
• W2002040571 cites W2024923170 @default.
• W2002040571 cites W2031082821 @default.
• W2002040571 cites W2051113354 @default.
• W2002040571 cites W2071075259 @default.
• W2002040571 cites W2072687123 @default.
• W2002040571 cites W2077397396 @default.
• W2002040571 cites W2082067420 @default.
• W2002040571 cites W2083240338 @default.
• W2002040571 cites W2090504233 @default.
• W2002040571 cites W2096576561 @default.
• W2002040571 cites W2097767970 @default.
• W2002040571 cites W2109384031 @default.
• W2002040571 cites W2127266698 @default.
• W2002040571 cites W2137035181 @default.
• W2002040571 cites W2153768622 @default.
• W2002040571 cites W2164481921 @default.
• W2002040571 cites W2331701350 @default.
• W2002040571 cites W4300196258 @default.
• W2002040571 doi "https://doi.org/10.1074/jbc.m501477200" @default.
• W2002040571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15722337" @default.
• W2002040571 hasPublicationYear "2005" @default.
• W2002040571 type Work @default.
• W2002040571 sameAs 2002040571 @default.
• W2002040571 citedByCount "20" @default.
• W2002040571 countsByYear W20020405712012 @default.
• W2002040571 countsByYear W20020405712013 @default.
• W2002040571 countsByYear W20020405712014 @default.
• W2002040571 countsByYear W20020405712015 @default.
• W2002040571 countsByYear W20020405712016 @default.
• W2002040571 countsByYear W20020405712017 @default.
• W2002040571 countsByYear W20020405712018 @default.
• W2002040571 crossrefType "journal-article" @default.
• W2002040571 hasAuthorship W2002040571A5005996443 @default.
• W2002040571 hasAuthorship W2002040571A5006057529 @default.
• W2002040571 hasAuthorship W2002040571A5018962313 @default.
• W2002040571 hasAuthorship W2002040571A5059538708 @default.
• W2002040571 hasAuthorship W2002040571A5066200247 @default.
• W2002040571 hasAuthorship W2002040571A5088789978 @default.
• W2002040571 hasBestOaLocation W20020405711 @default.
• W2002040571 hasConcept C11960822 @default.
• W2002040571 hasConcept C185592680 @default.
• W2002040571 hasConcept C55493867 @default.
• W2002040571 hasConcept C70721500 @default.
• W2002040571 hasConcept C86803240 @default.
• W2002040571 hasConcept C95444343 @default.
• W2002040571 hasConceptScore W2002040571C11960822 @default.
• W2002040571 hasConceptScore W2002040571C185592680 @default.
• W2002040571 hasConceptScore W2002040571C55493867 @default.
• W2002040571 hasConceptScore W2002040571C70721500 @default.
• W2002040571 hasConceptScore W2002040571C86803240 @default.
• W2002040571 hasConceptScore W2002040571C95444343 @default.
• W2002040571 hasIssue "17" @default.
• W2002040571 hasLocation W20020405711 @default.
• W2002040571 hasOpenAccess W2002040571 @default.
• W2002040571 hasPrimaryLocation W20020405711 @default.
• W2002040571 hasRelatedWork W2027150462 @default.
• W2002040571 hasRelatedWork W2078635122 @default.
• W2002040571 hasRelatedWork W2106969175 @default.
• W2002040571 hasRelatedWork W2115732451 @default.
• W2002040571 hasRelatedWork W2169846040 @default.
• W2002040571 hasRelatedWork W2317452501 @default.
• W2002040571 hasRelatedWork W2752261827 @default.
• W2002040571 hasRelatedWork W3026176877 @default.
• W2002040571 hasRelatedWork W3137497650 @default.
• W2002040571 hasRelatedWork W3207406928 @default.
• W2002040571 hasVolume "280" @default.
• W2002040571 isParatext "false" @default.
• W2002040571 isRetracted "false" @default.
• W2002040571 magId "2002040571" @default.
• W2002040571 workType "article" @default.